1. Guideline IHT. Development and manufacture of drug substances (chemical entities and biotechnological/biological entities) Q11. London: European medicines agency; 2011.
2. Guideline IHT. Pharmaceutical development Q8 (R2). 2009.
3. Guideline IHT. Specifications: test procedures and acceptance criteria for biotechnological/biological products Q6B. 1999.
4. FDA. Guidance for Industry PAT-A framework for innovative pharmaceutical development, Manufacturing, and Quality Assurance. wwwfdagov. 2004.
5. Rathore AS, Winkle H. Quality by design for biopharmaceuticals. Nat Biotech. 2009;27(1):26–34.